Ruth A Karron Selected Research

COVID-19

1/2022	Binding and neutralizing antibody responses to SARS-CoV-2 in very young children exceed those in adults.
1/2022	COVID-19 vaccine acceptance among Bangladeshi adults: Understanding predictors of vaccine intention to inform vaccine policy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruth A Karron Research Topics

Disease

10	Pneumonia (Pneumonitis) 11/2020 - 01/2007
10	Paramyxoviridae Infections (Parainfluenza) 12/2015 - 05/2003
8	Human Influenza (Influenza) 10/2017 - 11/2010
7	Infections 01/2022 - 05/2002
6	Respiratory Syncytial Virus Infections 01/2021 - 12/2004
6	Respiratory Sounds (Crackle) 11/2020 - 06/2004
3	Fever (Fevers) 11/2018 - 06/2013
3	Respiratory Tract Infections (Respiratory Tract Infection) 02/2016 - 08/2002
2	COVID-19 01/2022 - 01/2022
2	Malaria 01/2019 - 02/2016
2	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2019 - 02/2016
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2021
1	Asthma (Bronchial Asthma) 01/2020
1	Premature Birth (Birth, Premature) 01/2019
1	HIV Infections (HIV Infection) 01/2019
1	Communicable Diseases (Infectious Diseases) 10/2018
1	Bacterial Pneumonia 06/2017
1	Pneumococcal Pneumonia 06/2017
1	Pregnancy Complications 01/2017
1	Tachypnea 12/2016
1	Tachycardia (Tachyarrhythmias) 12/2016
1	Hypersensitivity (Allergy) 12/2015
1	Influenza in Birds (Avian Flu) 06/2009
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2007
1	Eosinophilia 01/2007
1	Inflammation (Inflammations) 06/2005
1	Cough 06/2004
1	Rhinorrhea 06/2004

Drug/Important Bio-Agent (IBA)

25	VaccinesIBA 01/2021 - 05/2003
5	Respiratory Syncytial Virus VaccinesIBA 01/2020 - 12/2004
4	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2017 - 06/2009
4	Anti-Bacterial Agents (Antibiotics)IBA 06/2017 - 04/2012
3	Neutralizing AntibodiesIBA 01/2022 - 10/2008
2	Monoclonal AntibodiesIBA 01/2020 - 12/2015
2	Immunoglobulin G (IgG)IBA 01/2019 - 10/2008
2	C-Reactive ProteinIBA 06/2017 - 06/2017
2	motavizumab (Numax)IBA 12/2016 - 12/2015
2	Glycoproteins (Glycoprotein)IBA 10/2008 - 06/2005
2	GTP-Binding Proteins (G-Protein)IBA 12/2004 - 05/2002
1	Pharmaceutical PreparationsIBA 01/2022
1	Coloring Agents (Dyes)IBA 06/2017
1	N-Acetylmuramoyl-L-alanine Amidase (Autolysin)IBA 06/2017
1	DNA (Deoxyribonucleic Acid)IBA 06/2017
1	Biological ProductsIBA 01/2017
1	ORALIT (ORS)IBA 12/2016
1	Immunoglobulins (Immunoglobulin)IBA 02/2016
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2013
1	Complement System Proteins (Complement)IBA 01/2007
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2007
1	CytokinesIBA 06/2004
1	Attenuated VaccinesIBA 02/2004
1	EnzymesIBA 08/2002
1	Amino Acids FDA Link 05/2002
1	AntibodiesIBA 05/2002
1	AA 193IBA 05/2002

Therapy/Procedure

1	Stethoscopes 11/2020
1	Contraindications 08/2016
1	Therapeutics 04/2012